Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Edralbrutinib |
Trade Name | |
Synonyms | TG-1701|TG 1701|TG1701|EBI-1459|EBI1459|EBI 1459|SHR 1459|SHR1459 |
Drug Descriptions |
Edralbrutinib (TG-1701) is a second-generation irreversible BTK inhibitor, which may result in decreased downstream signaling and reduced tumor growth (PMID: 34551904). |
DrugClasses | BTK inhibitor 37 |
CAS Registry Number | 1858206-58-2 |
NCIT ID | C175775 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Edralbrutinib | Edralbrutinib | 0 | 1 |
Edralbrutinib + Ublituximab + Umbralisib | Edralbrutinib Ublituximab Umbralisib | 0 | 1 |